Table 2:
Distribution of all benzodiazepine doses by route of administration, setting and age group (N=1170 in 460 patients)
| Lorazepam | Midazolam | Diazepam | Total | |||||
|---|---|---|---|---|---|---|---|---|
| N= 669 | N= 398 | N= 103 | N=1170 | |||||
| n | % | n | % | n | % | n | % | |
| Route of administration | ||||||||
| Intravenous | 638 | 95% | 159 | 40% | 21 | 20% | 818 | 70% |
| Intramuscular | 25 | 4% | 137 | 34% | 4 | 4% | 166 | 14% |
| Transmucosal* | 5 | 1% | 96 | 24% | 76 | 74% | 177 | 15% |
| Unknown | 1 | - | 6 | 2% | 2 | 2% | 9 | 1% |
| Setting | ||||||||
| Prior to EMS | 16 | 2% | 20 | 5% | 73 | 71% | 109 | 9% |
| EMS | 47 | 7% | 269 | 68% | 22 | 21% | 338 | 29% |
| ED | 606 | 91% | 109 | 27% | 8 | 8% | 728 | 62% |
| Age group | ||||||||
| Children** | 269 | 40% | 196 | 49% | 80 | 78% | 545 | 47% |
| Adult | 400 | 60% | 202 | 51% | 23 | 22% | 625 | 53% |
EMS- Emergency Medical Services; ED- Emergency Department
Transmucosal administration for diazepam was per rectum, while intranasal or buccal routes were used for lorazepam and midazolam.
The children group includes ages less than or equal to 17 years, the adult group includes those greater than 17.